You’re cruising through a neuro Q-bank and see a classic “progressive weakness” vignette. You pick ALS… and move on. But the real score boost comes from knowing why every other option is wrong—because USMLE questions love packaging similar symptoms and forcing you to separate upper motor neuron (UMN), lower motor neuron (LMN), sensory, autonomic, and cognitive clues. Let’s break down a high-yield ALS stem and then surgically eliminate the distractors.
Tag: Neurology > Neurodegenerative & Demyelinating
The Clinical Vignette (Q-bank style)
A 58-year-old man presents with 8 months of progressively worsening weakness. He first noticed difficulty turning keys and frequent tripping. He now has muscle cramps and visible twitching in his arms. He also reports that his speech has become “nasal” and he occasionally coughs while drinking water. Exam shows atrophy of the intrinsic hand muscles, fasciculations of the tongue, hyperreflexia, and spasticity in the legs. Sensation is intact. No bowel or bladder symptoms.
Most likely diagnosis?
A. Amyotrophic lateral sclerosis (ALS)
B. Multiple sclerosis
C. Myasthenia gravis
D. Guillain-Barré syndrome
E. Cervical spondylotic myelopathy
F. Parkinson disease
G. Huntington disease
H. Syringomyelia
I. Lambert-Eaton myasthenic syndrome
Correct Answer: A. Amyotrophic Lateral Sclerosis (ALS)
Why ALS fits this stem
ALS is the prototype for combined UMN + LMN signs with no sensory deficits.
Clues in the vignette:
- LMN signs: muscle atrophy, fasciculations (including tongue), cramps
- UMN signs: hyperreflexia, spasticity
- Bulbar involvement: dysarthria/dysphagia (nasal speech, cough with liquids)
- No sensory loss
- No bowel/bladder symptoms (helps separate from many spinal cord processes)
High-yield path/anatomy
ALS involves degeneration of:
- UMNs in the motor cortex/corticospinal tracts
- LMNs in the brainstem motor nuclei and anterior horn cells of the spinal cord
This combination is what creates the “mixed” exam.
Key ALS Facts You’re Expected to Know (USMLE gold)
Clinical
- Progressive, asymmetric weakness → spreads regionally
- Mixed UMN + LMN signs in the same patient
- Sensation typically preserved
- Can have pseudobulbar affect (emotional lability)
- Frontotemporal dementia can occur (ALS-FTD overlap), classically linked to C9orf72 expansions
Diagnostics (typical testing patterns)
- EMG/NCS: denervation and reinnervation changes (fibrillations, fasciculations, large motor unit potentials); conduction velocity usually not the primary issue
- MRI may be used to exclude structural lesions (e.g., cervical myelopathy)
Treatment (Step 2–relevant)
- Disease-modifying: riluzole (decreases glutamate) ± edaravone (free radical scavenger)
- Supportive: noninvasive ventilation, PEG feeding if severe dysphagia, multidisciplinary care
- Most common cause of death: respiratory failure
Boards favorite association
- SOD1 mutations (familial ALS)
- C9orf72 expansions (ALS + FTD association)
The Distractors: Why Each One Is Wrong
USMLE distractors are often “near misses.” Here’s how to eliminate them efficiently.
B. Multiple Sclerosis (MS) — Demyelinating, CNS, sensory/autonomic clues
Why it’s tempting: weakness, neuro symptoms
Why it’s wrong here:
- MS usually has dissemination in time and space (episodic neuro deficits with relapses/remissions)
- Sensory symptoms are common (paresthesias)
- Often includes optic neuritis (painful vision loss), internuclear ophthalmoplegia
- UMN signs can appear, but LMN findings like fasciculations/atrophy are not typical
High-yield MS anchor: CNS demyelination with oligoclonal bands in CSF; periventricular plaques.
C. Myasthenia Gravis (MG) — Fluctuating fatigable weakness, normal reflexes
Why it’s tempting: bulbar symptoms (dysphagia/dysarthria)
Why it’s wrong here:
- MG causes fatigable weakness that worsens with use and improves with rest
- Typically affects ocular muscles first (ptosis, diplopia)
- No UMN signs: reflexes are usually normal, no spasticity
- No LMN signs: fasciculations and muscle atrophy are not the hallmark
High-yield MG anchor: antibodies to postsynaptic ACh receptors; improved with acetylcholinesterase inhibitors; thymoma association.
D. Guillain-Barré Syndrome (GBS) — Acute ascending weakness + areflexia
Why it’s tempting: progressive weakness
Why it’s wrong here:
- Time course is wrong: GBS is acute/subacute (days to weeks), not 8 months
- Exam in GBS: areflexia/hyporeflexia, not hyperreflexia
- Often has autonomic instability (BP fluctuations, arrhythmias)
- Sensory symptoms can occur (paresthesias)
High-yield GBS anchor: demyelinating peripheral neuropathy; CSF shows albuminocytologic dissociation (high protein, normal WBC).
E. Cervical Spondylotic Myelopathy — Spinal cord compression mimicking UMN/LMN
Why it’s tempting: can produce mixed signs
Why it’s wrong here (based on stem):
- Myelopathy typically produces UMN signs below the lesion and LMN signs at the lesion level—this can look like ALS
- But you’d expect sensory changes (posterior column involvement, dermatomal symptoms), neck pain, or radicular pain
- Bowel/bladder dysfunction can occur in significant cord compression (stem says none)
- Tongue fasciculations suggest bulbar LMN involvement, which a cervical lesion wouldn’t explain
Board move: If the stem hints at a compressive lesion, the next step is often MRI cervical spine.
F. Parkinson Disease — Movement disorder, not primary weakness
Why it’s tempting: older patient, neurodegenerative
Why it’s wrong here:
- Parkinson disease is characterized by bradykinesia, resting tremor, rigidity, postural instability
- It does not cause UMN signs (hyperreflexia/spasticity) or LMN signs (atrophy/fasciculations)
- “Weakness” in Parkinson is usually perceived slowness, not true motor neuron weakness
High-yield PD anchor: loss of dopaminergic neurons in substantia nigra pars compacta; Lewy bodies (alpha-synuclein).
G. Huntington Disease — Chorea + psychiatric changes + dementia
Why it’s tempting: neurodegenerative
Why it’s wrong here:
- Core presentation: chorea, behavioral/psychiatric symptoms, progressive dementia
- Motor neuron signs (fasciculations, spasticity) are not typical
- Onset often earlier (30–50), autosomal dominant
High-yield HD anchor: CAG repeat expansion with anticipation; caudate atrophy → enlarged ventricles.
H. Syringomyelia — Cape-like pain/temp loss + hand weakness
Why it’s tempting: intrinsic hand muscle issues
Why it’s wrong here:
- Classic sensory finding: loss of pain and temperature in a cape-like distribution (spinothalamic crossing fibers)
- Can cause LMN signs at the level (hand weakness/atrophy), but UMN signs below may occur later
- The stem explicitly says sensation is intact, which fights this diagnosis
- Tongue fasciculations and bulbar signs are not typical
High-yield syrinx anchor: associated with Chiari I malformation.
I. Lambert-Eaton Myasthenic Syndrome (LEMS) — Proximal weakness + autonomic symptoms + improves with use
Why it’s tempting: weakness, can affect bulbar muscles sometimes
Why it’s wrong here:
- LEMS causes proximal weakness (hips/shoulders) and autonomic symptoms (dry mouth, impotence)
- Reflexes are decreased (often improve after brief exercise)
- No UMN signs like spasticity/hyperreflexia
- Often paraneoplastic (small cell lung cancer)
High-yield LEMS anchor: antibodies against presynaptic P/Q-type voltage-gated Ca channels → decreased ACh release; incremental response on repetitive stimulation.
Rapid Differentiation Table (What the test writer is really asking)
| Condition | UMN signs? | LMN signs? | Sensory loss? | Reflexes | Time course | Hallmark clue |
|---|---|---|---|---|---|---|
| ALS | Yes | Yes | No | Often ↑ | Months–years | Fasciculations + spasticity, intact sensation |
| MS | Yes | No | Often yes | Often ↑ | Relapsing | Optic neuritis, INO, oligoclonal bands |
| MG | No | No | No | Normal | Fluctuating | Fatigability, ptosis/diplopia |
| GBS | No | Yes (peripheral) | +/- | ↓/absent | Days–weeks | Ascending weakness, autonomic instability |
| Cervical myelopathy | Below lesion | At lesion | Often yes | Often ↑ below | Variable | Neck/radicular pain, bladder issues |
| LEMS | No | No | No | ↓ (improves) | Subacute | Autonomic sx; improves with use |
USMLE “Next Best Step” Add-On (common follow-up question)
If the question pivots from diagnosis to workup:
- Rule out mimics (especially compressive myelopathy): MRI brain/spine as appropriate
- Confirm motor neuron disease physiology: EMG
If it pivots to management:
- Start riluzole and discuss respiratory monitoring (FVC), swallow safety, and multidisciplinary support early.
Takeaway Pattern (burn this in)
When you see:
- Progressive weakness
- UMN + LMN signs together
- Fasciculations/atrophy
- No sensory deficits
…ALS should jump to the top of your list. And the fastest way to lock it in is to use the distractors as a checklist: sensory findings (MS/syrinx), fatigability (MG), acute areflexia (GBS), autonomic + incremental strength (LEMS), structural spine red flags (myelopathy).